So lets take a look at the logic behind microdosing GLP-1 and GIP meds (the combination found in Tirzepatide), and then address the crucial question: Is this even a good idea
This includes but is not limited to any form of consumption, medical treatment, veterinary use, or household application
[1] [2] This gradual escalation is designed to minimise gastrointestinal side effects, which are common with this class of medicine
Each batch is tested for purity, sequence accuracy, and quantity
Using smaller doses lowers these problems and makes the medication easier on the body
Pivotal clinical trials in continuous ketone monitoring, akin to currently available continuous glucose monitoring, are taking place in 2023 [53]